Chennai Meenakshi Multispeciality Hospital Limited has received notices from two significant shareholder groups proposing candidates for directorship at the upcoming 35th Annual General Meeting (AGM). This development highlights the active engagement of major shareholders in the company's governance.

Shareholder Proposals

Two shareholder groups, each holding over 10% of the company's share capital, have put forward their candidates for directorship:

1. G. Ra. Gokul and Abhinaya Gokul Group:

   • Shareholding: 751,433 shares (10.06% of share capital)
   • Proposed Candidate: Gomathi Radhakrishnan Gokul (DIN 01123161)

2. Gautham Srinivas and Aravind Srinivas Group:

   • Shareholding: 812,902 shares (10.88% of share capital)
   • Proposed Candidate: K.P. Gautham Srinivas (DIN 11104635)

Compliance with Regulatory Requirements

Both groups have adhered to the regulatory requirements by submitting the necessary deposit of Rs. 1.00 lakh each, as mandated under Section 160 of the Companies Act, 2013. This step ensures the formal consideration of their proposals at the upcoming AGM.

Board Approval and AGM Inclusion

The board of Chennai Meenakshi Multispeciality Hospital has approved both proposals. Consequently, resolutions for the appointment of these directors will be included in the notice for the 35th AGM.

Shareholder Notice Details

The LODR data provides additional insights into the notices received:

• The notices were addressed to the Board of Directors.
• Both proposed candidates, if elected, would serve as directors liable to retire by rotation.
• The company acknowledged receipt of the notices, confirming the inclusion of the resolutions in the AGM notice.

Implications for Corporate Governance

This move by major shareholders to nominate directors demonstrates an active interest in the company's leadership and governance. It also reflects the democratic process embedded in corporate governance structures, allowing significant shareholders to influence board composition.

The upcoming AGM will be a crucial event for Chennai Meenakshi Multispeciality Hospital, as shareholders will have the opportunity to vote on these directorship proposals, potentially shaping the future direction of the company's board.

Investors and stakeholders will be keenly watching the outcome of these nominations and their potential impact on the hospital's strategic direction and governance in the coming years.

Chennai Meenakshi Multispeciality Hospital Limited has received a special notice from three significant shareholders, proposing a change in the company's top leadership. The notice, filed under Section 115 of the Companies Act, 2013, requests the appointment of Mrs. Jayanthi Radhakrishnan as the new Managing Director of the company.

Shareholder Proposal

The special notice was submitted by three shareholders who collectively hold a 26.09% stake in the company:

1. Mrs. Jayanthi Radhakrishnan - 25.59% stake (1,911,660 shares)
2. Mr. Akash Prabhakar - 0.50% stake (37,000 shares)
3. Mrs. R. Gomathi - 0.0013% stake (100 shares)

Board Consideration and AGM Inclusion

The company has acknowledged receipt of the special notice and has taken the following steps:

1. The matter has been included in the agenda for the upcoming board meeting scheduled for September 3, 2025.
2. Following board consideration, the proposal for Mrs. Jayanthi Radhakrishnan's appointment as Managing Director will be included in the notice for the Annual General Meeting (AGM).
3. The AGM is scheduled to be held on or before September 30, 2025.

Company's Response

In response to the special notice, Chennai Meenakshi Multispeciality Hospital Limited has informed the shareholders that:

1. The special notice has been included in the agenda for the board meeting on September 3, 2025.
2. After board consideration, the item regarding Mrs. Jayanthi Radhakrishnan's appointment will be included in the AGM notice.
3. The company has officially communicated this information to the BSE Limited under Regulation 30 of SEBI Listing Regulations.

Implications

If approved, this change would mark a significant shift in the company's leadership. The current Chairman and Managing Director, R. Gomathi, has signed the company's response to the special notice, indicating their awareness and involvement in the process.

It's worth noting that according to the LODR data, if appointed, Mrs. Jayanthi Radhakrishnan will not be liable to retire by rotation, as per the terms of the Articles of Association of the Company.

The proposed leadership change comes at a time when the healthcare sector continues to evolve rapidly. Shareholders and market observers will be keenly watching the outcome of the board meeting and subsequent AGM for its potential impact on the company's future direction and strategy.